FindTrial
Sign In

A multicenter real-world study on consolidation treatment with PD-L1/PD-1 immune checkpoint inhibitors in limited-stage small cell lung cancer after no progression with concurrent chemoradiotherapy

A multicenter real-world study on consolidation treatment with PD-L1/PD-1 immune checkpoint inhibitors in limited-stage small cell lung cancer after no progression with concurrent chemoradiotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600125754
Enrollment
Unknown
Registered
2026-05-31
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

small cell lung cancer

Interventions

Case series :none

Sponsors

Cancer Hospital Affiliated to Shandong First Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Sign the informed consent form and voluntarily join this study; 2. Confirmed by histopathological/cytological examination to be limited-stage small cell lung cancer; 3. Age >=18 years; 4. Investigator determines that the patient can receive PD-L1/PD-1 immune checkpoint inhibitor treatment; 5. No progression after previous concurrent chemoradiotherapy.

Exclusion criteria

Exclusion criteria: 1. Patients who are simultaneously receiving other immunological drugs or therapies; 2. Patients who are participating in other interventional studies; 3. Patients who have concurrent other malignant tumors; 4. Patients with missing key study-related data.

Design outcomes

Primary

MeasureTime frame
Progression-free survival;—

Secondary

MeasureTime frame
overall response rate;duration of response;disease control rate;overall survival;safety;—

Countries

China

Contacts

Public ContactYu Jinming/ Meng Xiangjiao

Cancer Hospital Affiliated to Shandong First Medical University

mengxiangjiao@126.com+86 137 9315 0996

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026